DNA vaccines
US11384388B2 · kind B2 · utility
1Cited by
14References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 2019 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Oct 24, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y113/12007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An in vitro process for the production of closed linear deoxyribonucleic acid (DNA) comprises (a) contacting a DNA template comprising at least one protelomerase target sequence with at least one DNA polymerase in the presence of one or more primers under conditions promoting amplification of the template; and (b) contacting amplified DNA produced in (a) with at least one protelomerase under conditions promoting production of closed linear DNA. A kit provides components necessary in the process.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.